US Stock MarketDetailed Quotes

MYMD MyMD Pharmaceuticals

Watchlist
  • 2.000
  • 0.000-0.01%
Trading May 23 13:15 ET
4.61MMarket Cap-215P/E (TTM)

MyMD Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.86%-1.91M
-5.79%-12.98M
14.04%-1.93M
22.78%-3.16M
-9.86%-3.92M
-67.85%-3.97M
37.13%-12.27M
53.28%-2.25M
36.59%-4.09M
47.17%-3.57M
Net income from continuing operations
-548.27%-9.8M
73.68%-4M
36.90%-2.36M
209.46%4.04M
-14.62%-4.17M
63.33%-1.51M
49.15%-15.2M
-15.61%-3.75M
32.44%-3.69M
79.90%-3.64M
Operating gains losses
766.95%7.03M
-215,479.21%-12.85M
-286,906.01%-3.2M
-642,763.92%-7.71M
-44,166.38%-880.89K
-64,007.58%-1.05M
-99.96%5.96K
299.46%1.12K
-99.99%1.2K
--2K
Other non cash items
-40.48%29.26K
----
----
--0
1,800.02%93.41K
207.29%49.16K
----
----
196.71%267.05K
110.33%4.92K
Change In working capital
122.82%336.91K
-63.41%815.52K
55.56%2.15M
117.40%129.68K
115.22%9.64K
-189.25%-1.48M
143.02%2.23M
188.37%1.38M
30.40%-745.4K
98.17%-63.32K
-Change in prepaid assets
197.51%168.07K
-160.57%-327.44K
-13.36%370.25K
-33.31%252.28K
-59.58%-777.62K
-177.56%-172.35K
159.22%540.56K
180.59%427.34K
116.49%378.28K
11.91%-487.29K
-Change in payables and accrued expense
99.25%-9.83K
-38.16%1.04M
76.00%1.68M
89.09%-122.61K
85.93%787.25K
-191.10%-1.3M
139.51%1.69M
192.37%955.91K
9.76%-1.12M
114.52%423.42K
-Change in other current liabilities
-357.32%-404
----
----
----
----
--157
----
----
----
----
-Change in other working capital
--179.08K
5,114.40%99.96K
23,603.56%99.79K
-98.92%6
----
----
2,466.67%1.92K
178.40%421
210.67%553
--547
Cash from discontinued investing activities
Operating cash flow
51.86%-1.91M
-5.79%-12.98M
14.04%-1.93M
22.78%-3.16M
-9.86%-3.92M
-67.85%-3.97M
37.13%-12.27M
53.28%-2.25M
36.59%-4.09M
47.17%-3.57M
Investing cash flow
Cash flow from continuing investing activities
106.49%732.02K
-73.30%1.85M
120.80%5.93M
248.20%3.36M
9.48%3.83M
-475.89%-11.27M
-65.17%6.91M
-10.37%2.69M
-141.25%-2.27M
-69.23%3.49M
Net investment purchase and sale
106.49%732.02K
-73.30%1.85M
120.80%5.93M
248.20%3.36M
9.48%3.83M
-475.89%-11.27M
-62.57%6.91M
-10.37%2.69M
-141.25%-2.27M
-64.97%3.49M
Cash from discontinued investing activities
Investing cash flow
106.49%732.02K
-73.30%1.85M
120.80%5.93M
248.20%3.36M
9.48%3.83M
-475.89%-11.27M
-65.17%6.91M
-10.37%2.69M
-141.25%-2.27M
-69.23%3.49M
Financing cash flow
Cash flow from continuing financing activities
-108.68%-1.28M
135.44%13.07M
-1.62M
0
0
14.69M
7,447.67%5.55M
0
2,748.10%5.55M
0
Net common stock issuance
--0
--0
--0
----
----
--14.69M
--5.55M
--0
----
----
Net preferred stock issuance
---141.58K
--14.52M
---166.73K
--0
--14.69M
--0
--0
--0
--0
--0
Cash dividends paid
---1.13M
---1.45M
----
----
----
--0
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
-108.68%-1.28M
135.44%13.07M
---1.62M
--0
--0
--14.69M
7,447.67%5.55M
--0
2,748.10%5.55M
--0
Net cash flow
Beginning cash position
257.90%2.68M
34.74%749.09K
-3.75%298.32K
-91.59%93.82K
-84.15%188.55K
34.74%749.09K
274.93%555.97K
-77.46%309.93K
-47.58%1.12M
171.96%1.19M
Current changes in cash
-338.03%-2.46M
900.36%1.93M
442.55%2.38M
125.38%204.5K
-28.62%-94.73K
-188.52%-560.54K
-52.63%193.12K
153.62%439.16K
-7.08%-805.65K
-104.36%-73.65K
End cash Position
19.68%225.66K
257.90%2.68M
257.90%2.68M
-3.75%298.32K
-91.59%93.82K
-84.15%188.55K
34.74%749.09K
34.74%749.09K
-77.46%309.93K
-47.58%1.12M
Free cash flow
51.86%-1.91M
-5.79%-12.98M
14.04%-1.93M
22.78%-3.16M
-9.86%-3.92M
-67.85%-3.97M
37.13%-12.27M
53.28%-2.25M
36.59%-4.09M
47.17%-3.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.86%-1.91M-5.79%-12.98M14.04%-1.93M22.78%-3.16M-9.86%-3.92M-67.85%-3.97M37.13%-12.27M53.28%-2.25M36.59%-4.09M47.17%-3.57M
Net income from continuing operations -548.27%-9.8M73.68%-4M36.90%-2.36M209.46%4.04M-14.62%-4.17M63.33%-1.51M49.15%-15.2M-15.61%-3.75M32.44%-3.69M79.90%-3.64M
Operating gains losses 766.95%7.03M-215,479.21%-12.85M-286,906.01%-3.2M-642,763.92%-7.71M-44,166.38%-880.89K-64,007.58%-1.05M-99.96%5.96K299.46%1.12K-99.99%1.2K--2K
Other non cash items -40.48%29.26K----------01,800.02%93.41K207.29%49.16K--------196.71%267.05K110.33%4.92K
Change In working capital 122.82%336.91K-63.41%815.52K55.56%2.15M117.40%129.68K115.22%9.64K-189.25%-1.48M143.02%2.23M188.37%1.38M30.40%-745.4K98.17%-63.32K
-Change in prepaid assets 197.51%168.07K-160.57%-327.44K-13.36%370.25K-33.31%252.28K-59.58%-777.62K-177.56%-172.35K159.22%540.56K180.59%427.34K116.49%378.28K11.91%-487.29K
-Change in payables and accrued expense 99.25%-9.83K-38.16%1.04M76.00%1.68M89.09%-122.61K85.93%787.25K-191.10%-1.3M139.51%1.69M192.37%955.91K9.76%-1.12M114.52%423.42K
-Change in other current liabilities -357.32%-404------------------157----------------
-Change in other working capital --179.08K5,114.40%99.96K23,603.56%99.79K-98.92%6--------2,466.67%1.92K178.40%421210.67%553--547
Cash from discontinued investing activities
Operating cash flow 51.86%-1.91M-5.79%-12.98M14.04%-1.93M22.78%-3.16M-9.86%-3.92M-67.85%-3.97M37.13%-12.27M53.28%-2.25M36.59%-4.09M47.17%-3.57M
Investing cash flow
Cash flow from continuing investing activities 106.49%732.02K-73.30%1.85M120.80%5.93M248.20%3.36M9.48%3.83M-475.89%-11.27M-65.17%6.91M-10.37%2.69M-141.25%-2.27M-69.23%3.49M
Net investment purchase and sale 106.49%732.02K-73.30%1.85M120.80%5.93M248.20%3.36M9.48%3.83M-475.89%-11.27M-62.57%6.91M-10.37%2.69M-141.25%-2.27M-64.97%3.49M
Cash from discontinued investing activities
Investing cash flow 106.49%732.02K-73.30%1.85M120.80%5.93M248.20%3.36M9.48%3.83M-475.89%-11.27M-65.17%6.91M-10.37%2.69M-141.25%-2.27M-69.23%3.49M
Financing cash flow
Cash flow from continuing financing activities -108.68%-1.28M135.44%13.07M-1.62M0014.69M7,447.67%5.55M02,748.10%5.55M0
Net common stock issuance --0--0--0----------14.69M--5.55M--0--------
Net preferred stock issuance ---141.58K--14.52M---166.73K--0--14.69M--0--0--0--0--0
Cash dividends paid ---1.13M---1.45M--------------0--0------------
Cash from discontinued financing activities
Financing cash flow -108.68%-1.28M135.44%13.07M---1.62M--0--0--14.69M7,447.67%5.55M--02,748.10%5.55M--0
Net cash flow
Beginning cash position 257.90%2.68M34.74%749.09K-3.75%298.32K-91.59%93.82K-84.15%188.55K34.74%749.09K274.93%555.97K-77.46%309.93K-47.58%1.12M171.96%1.19M
Current changes in cash -338.03%-2.46M900.36%1.93M442.55%2.38M125.38%204.5K-28.62%-94.73K-188.52%-560.54K-52.63%193.12K153.62%439.16K-7.08%-805.65K-104.36%-73.65K
End cash Position 19.68%225.66K257.90%2.68M257.90%2.68M-3.75%298.32K-91.59%93.82K-84.15%188.55K34.74%749.09K34.74%749.09K-77.46%309.93K-47.58%1.12M
Free cash flow 51.86%-1.91M-5.79%-12.98M14.04%-1.93M22.78%-3.16M-9.86%-3.92M-67.85%-3.97M37.13%-12.27M53.28%-2.25M36.59%-4.09M47.17%-3.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg